Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vicagrel vs clopidogrel in PCI-treated coronary artery disease (phase II)
CTR20180811Phase 2Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vicagrel in coronary arteriosclerosis, thrombosis, sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started May 2018; status: completed.
02
Drugs
vicagrel
03
Conditions
coronary arteriosclerosisthrombosis
Beyond the preview
Go deeper on CTR20180811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180811.